Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Brief ReportBRIEF COMMUNICATION

18F-FDG PET Database of Longitudinally Confirmed Healthy Elderly Individuals Improves Detection of Mild Cognitive Impairment and Alzheimer's Disease

Lisa Mosconi, Wai Hon Tsui, Alberto Pupi, Susan De Santi, Alexander Drzezga, Satoshi Minoshima and Mony J. de Leon
Journal of Nuclear Medicine July 2007, 48 (7) 1129-1134; DOI: https://doi.org/10.2967/jnumed.107.040675
Lisa Mosconi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wai Hon Tsui
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alberto Pupi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susan De Santi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexander Drzezga
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Satoshi Minoshima
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mony J. de Leon
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • FIGURE 1. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1. 

    Standardized ROIs. Predefined anatomic surface ROIs (in red) are superimposed onto (from left to right) right and left lateral and right and left medial views of standardized brain template showing surface projection maps of statistical abnormalities in AD patients as compared with NLs. z scores are represented on color-coded scale ranging from 0 (black) to 5 (red). Typical AD-related CMRglc reductions in parietotemporal and posterior cingulate cortices are evident in ROIs.

  • FIGURE 2. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2. 

    Database effects on 18F-FDG PET diagnostic accuracy. (A and B) Effects in AD-affected brain regions discriminating AD patients (A) and MCI patients (B) from NLs using DB− (white bars) and DB+ (hatched bars). (C and D) Effects of using DB− (top row) and DB+ (bottom row) to create 3D-SSP maps are depicted in 2 representative AD (C) and MCI (D) patients. 3D-SSP maps showing CMRglc reductions in AD and MCI patients are displayed on same color-coded z score scale. IPL = inferior parietal lobe; L = left hemisphere; LTL = lateral temporal lobe; PCC = posterior cingulate cortex; R = right hemisphere.

  • FIGURE 3. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3. 

    18F-FDG PET diagnostic accuracy. Percentage of NLs (n = 19), MCI patients (n = 37), patients with mild AD (n = 15), and patients with moderate to severe (mod-to-sev) AD (n = 18) correctly identified using DB− (white bars) and DB+ (hatched bars).

  • FIGURE 4. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 4. 

    Comparison between NL-MCI patients and NL-NLs. Brain regions showing baseline CMRglc reductions in 22 NL-MCI patients and 22 age-matched NL-NLs are displayed on standardized T1-weighted MRI template in axial view (from left to right: z = 29 to z = 64 mm, every 5 mm, relative to anterior commissure–posterior commissure line). Voxelwise group comparison of spatially normalized 18F-FDG PET scans was performed with t test for independent samples accounting for global CMRglc (3,5). CMRglc reductions in NL-MCI patients compared with NL-NLs were evident mainly in temporal, posterior cingulate, and parietal cortices. Color scale indicate P values corresponding to significance of CMRglc reductions, ranging from P = 0.05 to P = 0.01, uncorrected for multiple comparisons. PCC = posterior cingulate cortex; P Cx = parietal cortex; T Cx = temporal cortex.

Tables

  • Figures
    • View popup
    TABLE 1

    Clinical Characteristics of Participants

    Reference databaseClinical groups
    CharacteristicDB−DB+NLMCIMild ADModerate-to-severe AD
    n555519371518
    Age* (y)69 (7), 50–8268 (7), 50–8068 (4), 55–8070 (7), 50–8269 (8), 50–8365 (7), 51–80
    Education* (y)15 (2), 12–1815 (2), 12–1814 (3), 11–1811 (4), 8–18†12 (3), 9–18†10 (3), 8–18†
    % Female555658605367
    MMSE*29 (1), 28–3029 (1), 28–3029 (1), 28–3027 (2), 24–3026 (2), 24–2819 (4), 10–23†‡§
    • ↵* Values are mean, with SD in parentheses, followed by range.

    • ↵† Lower than NL, P ≤ 0.05.

    • ↵‡ Lower than MCI, P ≤ 0.05.

    • ↵§ Lower than mild AD, P ≤ 0.05.

    • View popup
    TABLE 2

    z Scores in Clinical Groups by Reference Database

    NLMCIAD
    ROIDB−DB+DB−DB+DB−DB+
    IPL L0.47 (0.23)0.49 (0.21)1.04 (0.93)1.56 (0.66)*1.48 (0.46)2.49 (0.83)*
    IPL R0.44 (0.24)0.48 (0.22)0.87 (0.87)1.25 (0.89)*1.52 (0.91)2.43 (0.93)*
    LTL L0.47 (0.42)0.41 (0.23)1.26 (0.85)1.32 (0.91)2.13 (0.79)2.93 (0.35)*
    LTL R0.43 (0.38)0.51 (0.38)1.11 (1.08)1.27 (0.94)*2.16 (1.03)2.74 (0.93)*
    OCC L0.35 (0.42)0.32 (0.31)0.97 (0.40)0.05 (0.51)1.35 (0.56)1.40 (0.72)
    OCC R0.48 (0.61)0.44 (0.50)0.78 (0.65)0.85 (0.57)1.12 (0.66)1.34 (0.52)
    PCC L0.71 (0.62)0.82 (0.86)1.10 (0.86)1.86 (0.82)*1.81 (0.53)3.51 (0.45)*
    PCC R0.62 (0.76)0.74 (0.67)0.98 (0.89)1.72 (0.98)*1.50 (1.02)2.72 (1.13)*
    PFC L0.85 (0.84)0.73 (0.65)1.13 (0.85)1.10 (0.95)1.92 (0.44)2.28 (0.60)
    PFC R1.02 (0.75)0.85 (0.92)1.15 (0.79)1.09 (0.94)1.54 (1.08)1.80 (1.12)
    S-M L0.40 (0.41)0.34 (0.23)0.44 (0.31)0.54 (0.54)0.47 (0.24)0.51 (0.39)
    S-M R0.33 (0.35)0.32 (0.33)0.32 (0.52)0.43 (0.57)0.35 (0.53)0.53 (0.50)
    • ↵* DB+ higher than DB−, P ≤ 0.05.

    • IPL = inferior parietal lobe; LTL = lateral temporal lobe; OCC = occipital cortex; PCC = posterior cingulate cortex; PFC = prefrontal cortex; S-M = sensorimotor cortex; L = left hemisphere, R = right hemisphere.

    • Values in parentheses are SDs.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 48 (7)
Journal of Nuclear Medicine
Vol. 48, Issue 7
July 2007
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
18F-FDG PET Database of Longitudinally Confirmed Healthy Elderly Individuals Improves Detection of Mild Cognitive Impairment and Alzheimer's Disease
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
18F-FDG PET Database of Longitudinally Confirmed Healthy Elderly Individuals Improves Detection of Mild Cognitive Impairment and Alzheimer's Disease
Lisa Mosconi, Wai Hon Tsui, Alberto Pupi, Susan De Santi, Alexander Drzezga, Satoshi Minoshima, Mony J. de Leon
Journal of Nuclear Medicine Jul 2007, 48 (7) 1129-1134; DOI: 10.2967/jnumed.107.040675

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
18F-FDG PET Database of Longitudinally Confirmed Healthy Elderly Individuals Improves Detection of Mild Cognitive Impairment and Alzheimer's Disease
Lisa Mosconi, Wai Hon Tsui, Alberto Pupi, Susan De Santi, Alexander Drzezga, Satoshi Minoshima, Mony J. de Leon
Journal of Nuclear Medicine Jul 2007, 48 (7) 1129-1134; DOI: 10.2967/jnumed.107.040675
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Modeling the Effects of Age and Sex on Normal Pediatric Brain Metabolism Using 18F-FDG PET/CT
  • Effectiveness and Safety of 18F-FDG PET in the Evaluation of Dementia: A Review of the Recent Literature
  • Molecular imaging in the diagnosis of Alzheimer's disease: visual assessment of [11C]PIB and [18F]FDDNP PET images
  • Declining brain glucose metabolism in normal individuals with a maternal history of Alzheimer disease
  • Multicenter Standardized 18F-FDG PET Diagnosis of Mild Cognitive Impairment, Alzheimer's Disease, and Other Dementias
  • Google Scholar

More in this TOC Section

  • Measuring Total Metabolic Tumor Volume from 18F-FDG PET: A Reality Check
  • Bioanalytic Hybrid System Merging 3-Dimensional Cell Culture and Chromatographic Precision for Unprecedented Preclinical Insights in Molecular Imaging
  • Radiances of Cerenkov-Emitting Radionuclides on the In Vivo Imaging System
Show more BRIEF COMMUNICATION

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire